NASDAQ:BCYC

Bicycle Therapeutics Stock Forecast

etoro logo Buy BCYC
*Your capital is at risk
$4.16
+0 (+0%)
At Close: Jul 21, 2026
AI Analysis AI Analysis of BCYC AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BCYC to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Bicycle Therapeutics PLC stock price ended at $4.16 on Tuesday, after losing 0%
(Updated on Jul 21, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 20, 2026

No changes to the price of Bicycle Therapeutics PLC stock on the last trading day (Tuesday, 21st Jul 2026). During the last trading day the stock fluctuated 1.82% from a day low at $4.12 to a day high of $4.20. The price has fallen in 6 of the last 10 days and is down by -5.02% for this period.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.48% during the next 3 months and, with a 90% probability hold a price between $3.14 and $3.77 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BCYC Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 24, 2026, and so far it has risen 5.05%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Bicycle Therapeutics PLC stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $4.21 and $4.18. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Support, Risk & Stop-loss for Bicycle Therapeutics PLC stock

Bicycle Therapeutics PLC finds support from accumulated volume at $4.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0750 between high and low, or 1.82%. For the last week the stock has had daily average volatility of 3.02%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BCYC) For The Upcoming Trading Day Of Wednesday 22nd

For the upcoming trading day on Wednesday, 22nd we expect Bicycle Therapeutics PLC to open at $4.16, and during the day (based on 14 day Average True Range), to move between $4.07 and $4.25, which gives a possible trading interval of +/-$0.172 (+/-4.23%) up or down from last closing price. If Bicycle Therapeutics PLC takes out the full calculated possible swing range there will be an estimated 4.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.15 (0.24%) than the resistance at $4.18 (0.48%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bicycle Therapeutics PLC stock A Buy?

Bicycle Therapeutics PLC holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.650 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 22, 2026 - $4.16 ( 0.0401%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BCYC Performance

Trading levels for BCYC

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.23 1.76%
R2 4.20 1.07%
R1 4.19 0.649%
Price 4.16
S1 4.13 -0.729%
S2 4.11 -1.15%
S3 4.08 -1.84%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.35 4.57%
R2 4.20 0.96%
R1 4.18 0.481%
Price 4.16
S1 4.15 -0.240%
S2 4.10 -1.44%
S3 4.04 -2.88%

FAQ

What is the symbol for Bicycle Therapeutics PLC Stock and on which exchange is it traded?
The symbol for Bicycle Therapeutics PLC is BCYC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bicycle Therapeutics PLC Stock?
Bicycle Therapeutics PLC holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Bicycle Therapeutics PLC Stock?
Bicycle Therapeutics PLC Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bicycle Therapeutics PLC Stock.

What's the current price of Bicycle Therapeutics PLC Stock?
As of the end of day on the Jul 21, 2026, the price of an Bicycle Therapeutics PLC (BCYC) share was $4.16.

What is the 52-week high and low for Bicycle Therapeutics PLC Stock?
The 52-week high for Bicycle Therapeutics PLC Stock is $9.18 and the 52-week low is $3.92.

What is the market capitalization of Bicycle Therapeutics PLC Stock?
As of the Jul 21, 2026, the market capitalization of Bicycle Therapeutics PLC is 288.681M.

When is the next earnings date for Bicycle Therapeutics PLC?
The upcoming earnings date for Bicycle Therapeutics PLC is Aug 14, 2026.
Click to get the best stock tips daily for free!
ABOUT BICYCLE THERAPEUTICS PLC
Bicycle Therapeutics
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidates also comprise BT5528, a BTC that is in a Phase I/II clinical trial ...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.35% Jul 13
JLL
$299.78
8.73% Jun 24
NMRK
$15.02
3.26% Jun 24
NESR
$25.07
8.62% Jun 23
CAG
$13.43
9.20% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE